Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

gpIIb/IIIa antagonist selected for clinical evaluation at DuPont Merck

Sep. 27, 1996

DuPont Merck proposes new standards for warfarin products

Sep. 27, 1996

Thrombin inhibitors with improved selectivity from Servier

Sep. 27, 1996

Antiplatelet ketoprofen analogue from Fuji Chem.

Sep. 20, 1996

Bristol-Myers Squibb to acquire prostacyclin analogue for claudication

Sep. 20, 1996

New prostacyclins from Asahi Glass

Sep. 20, 1996

Anticoagulant for treating blood clots approved in Canada

Sep. 20, 1996

R&D in blood coauglation at Daiichi

Sep. 13, 1996

Review on gpIIb/IIIa antagonists for ischemic complications

Sep. 13, 1996

Antiplatelet agents reported by Lilly

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...